Abstract
Functional neuroimaging
Although the primary imaging modality in the management of epilepsy is magnetic resonance imaging MRI, functional neuroimaging with positron-emission tomography (PET) and single photon emission computed tomography (SPECT) often provides complementary information and, in a number of situations, provides unique information that cannot be obtained with MRI. The most commonly used PET tracers used for epilepsy evaluation are 2-deoxy-2-[18F]fluoro-d-glucose (FDG) and [11C]flumazenil (FMZ). Recently, interictal PET with alpha-[11C]methyl-l-tryptophan was found to be highly specific for the epileptic focus and can differentiate between epileptogenic and nonepileptogenic lesions in the same patient (e.g., in patients with tuberous sclerosis).
Discussion
In this review, we discuss clinical applications of these three PET tracers in drug-resistant temporal and extratemporal lobe epilepsy, selected epilepsy syndromes of childhood, lesional and nonlesional epilepsy, and the challenges of imaging secondary epileptic foci. A brief discussion of SPECT applications in epilepsy is also included. With further development of new tracers highly sensitive and specific for epileptogenic brain regions, the presurgical evaluation of refractory epilepsy will be greatly facilitated. Approximately 0.5 to 1.0% of the population suffer from epilepsy, of which 15–20% are intractable. Infants and children, whose seizures have a focal onset are refractory to anticonvulsants and are prolonged, tend to have the worst cognitive outcome [Meador KJ, Neurology 58 (Suppl 5):S21–S26, 2002]. Seizures themselves affect the developing brain and contribute to an adverse neurologic outcome (Holmes, Pediatric Neurology 33:1–110, 2005).
Conclusion
Therefore, in treating children with intractable epilepsy, it is important to consider seizure control and to give allowance for normal cognitive development.
Similar content being viewed by others
References
Asano E, Chugani DC, Muzik O, Shen C, Juhász C, Janisse J, Ager J, Canady A, Shah JR, Shah AK, Watson C, Chugani HT (2000) Multimodality imaging for improved detection of epileptogenic lesions in children with tuberous sclerosis complex. Neurology 54:1976–1984
Asano E, Chugani DC, Juhász C, Muzik O, Chugani HT (2001) Surgical treatment of West syndrome. Brain Dev 23:668–676
Benedek K, Juhász C, Muzik O, Chugani DC, Chugani HT (2004) Metabolic changes of subcortical structures in intractable focal epilepsy. Epilepsia 45:1100–1105
Benedek K, Juhász C, Chugani DC, Muzik O, Chugani HT (2006) Longitudinal changes in cortical glucose hypometabolism in children with intractable epilepsy. J Child Neurol 21(1):26–30
Chiron C, Vera P, Kaminska A, Hollo A, Cieuta C, Ville D, Dulac O (1999) Single-photon emission computed tomography: ictal perfusion in childhood epilepsies. Brain Dev 21:444–446
Chugani DC, Chugani HT, Muzik O, Shah JR, Shah AK, Canady A, Mangner TJ, Chakraborty PK (1998) Imaging epileptogenic tubers in children with tuberous sclerosis complex using alpha-[11C]methyl-l-tryptophan positron emission tomography. Ann Neurol 44:858–866
Chugani HT, Shields WD, Shewmon DA, Olson DM, Phelps ME, Peacock WJ (1990) Infantile spasms: I. PET identifies focal cortical dysgenesis in cryptogenic cases for surgical treatment. Ann Neurol 27:406–413
Chugani HT, Shewmon DA, Shields WD, Sankar R, Comair Y, Vinters HV, Peacock WJ (1993) Surgery for intractable infantile spasms: neuroimaging perspectives. Epilepsia 34:764–771
Chugani HT, Shewmon D, Khanna S, Phelps ME (1993) Interictal and postictal focal hypermetabolism on positron emission tomography. Pediatr Neurol 9:10–15
Chugani HT, Conti JR (1996) Etiologic classification of infantile spasms in 140 cases: role of positron emission tomography. J Child Neurol 11:44–48
Chugani HT, Da Silva E, Chugani DC (1996) Infantile spasms: III. Prognostic implications of bitemporal hypometabolism on positron emission tomography. Ann Neurol 39:643–649
Cross JH, Gordon I, Connelly A, Jackson GD, Johnson CL, Neville BG, Gadian DG (1997) Interictal 99Tc(m) HMPAO SPECT and 1H MRS in children with temporal lobe epilepsy. Epilepsia 38:338–345
Da Silva EA, Chugani DC, Muzik O, Chugani HT (1997) Identification of frontal lobe epileptic foci in children using positron emission tomography. Epilepsia 38:1198–1208
Duchowny M, Jayakar P, Resnick T, Harvey AS, Alvarez L, Dean P, Gilman J, Yaylali I, Morrison G, Prats A, Altman N, Birchansky S, Bruce J (1998) Epilepsy surgery in the first three years of life. Epilepsia 39:737–743
Eliashiv SD, Dewar S, Wainwright I, Engel J Jr, Fried I (1997) Long-term follow-up after temporal lobe resection for lesions associated with chronic seizures. Neurology 48:621–626
Engel J (1996) Surgery for seizures. N Engl J Med 334:647–652
Engel J Jr, van Ness PC, Rasmussen TB, Ojemann LM (1993) Outcome with respect to epileptic seizures. In: Engel J Jr (ed) Surgical treatment of the epilepsies, 2nd edn. Raven, New York, pp 609–622
Frost JJ, Mayberg HS, Fisher RS, Douglass KH, Dannals RF, Links JM, Wilson AA, Ravert HT, Rosenbaum AE, Snyder SH (1988) Mu-opiate receptors measured by positron emission tomography are increased in temporal lobe epilepsy. Ann Neurol 23:231–237
Gaillard WD, Bhatia S, Bookheimer SY, Fazilat S, Sato S, Theodore WH (1995) FDG-PET and volumetric MRI in the evaluation of patients with partial epilepsy. Neurology 45:123–126
Gaillard WD, Kopylev L, Weinstein S, Conry J, Pearl PL, Spanaki MV, Fazilat S, Fazilat S, Venzina LG, Dubovsky E, Theodore WH (2002) Low incidence of abnormal (18)FDG-PET in children with new onset partial epilepsy: a prospective study. Neurology 58:717–722
Hammers A, Koepp MJ, Richardson MP, Labbe C, Brooks DJ, Cunningham VJ, Duncan JS (2001) Central benzodiazepine receptors in malformations of cortical development: A quantitative study. Brain 124:1555–1565
Harvey AS, Bowe JM, Hopkins IJ, Shield LK, Cook DJ, Berkovic SF (1993) Ictal 99mTc-HMPAO single photon emission computed tomography in children with temporal lobe epilepsy. Epilepsia 34:869–877
Heiskala H, Launes J, Pihko H, Nikkinen P, Santavuori P (1993) Brain perfusion SPECT in children with frequent fits. Brain Dev 15:214–218
Henry TR, Chugani HT, Abou-Khalil BW et al (1993) Positron emission tomography. In: Engel J Jr (ed) Surgical treatment of the epilepsies, 2nd edn. Raven, New York, pp 211–243
Henry TR, Frey KA, Sackellares JC, Gilman S, Koeppe RA, Brunberg JA, Ross DA, Berent S, Young AB, Kuhl DE (1993) In vivo cerebral metabolism and central benzodiazepine-receptor binding in temporal lobe epilepsy. Neurology 43:1998–2006
Holmes GL (2005) Effects of seizures on brain development: lessons from the laboratory. Pediatr Neurol 33:1–110
Iinuma K, Yokoyama H, Otsuki T, Yanai K, Watanabe T, Ido T, Itoh M (1993) Histamine H1 receptors in complex partial seizures. Lancet 341:238
Juhász C, Chugani HT (2003) Imaging the epileptic brain with positron emission tomography. Neuroimaging Clin N Am 13:705–716
Juhász C, Nagy F, Muzik O, Watson C, Shah J, Chugani HT (1999) 11C-flumazenil PET in patients with epilepsy with dual pathology. Epilepsia 40:566–574
Juhász C, Chugani DC, Muzik O, Watson C, Shah J, Shah A, Chugani HT (2000) Electroclinical correlates of flumazenil and fluorodeoxyglucose PET abnormalities in lesional epilepsy. Neurology 55:825–834
Juhász C, Chugani DC, Muzik O, Shah A, Shah J, Watson C, Canady A, Chugani HT (2001) Relationship of flumazenil and glucose PET abnormalities to neocortical epilepsy surgery outcome. Neurology 56:1650–1658
Juhász C, Chugani DC, Muzik O, Shah A, Asano E, Mangner TJ, Chakraborty PK, Sood S, Chugani HT (2003) Alpha-methyl-l-tryptophan PET detects epileptogenic cortex in children with intractable epilepsy. Neurology 60:960–968
Juhász C, Chugani DC, Muzik O, Asano E, Shah A, Shah J, Sood S, Kagawa K, Benedek K, Chugani HT (2003) Cortical GABAA receptor binding abnormalities remote from the primary epileptic focus: what is their electrophysiologic and clinical significance? Epilepsia 44(Suppl. 9):311–312
Kagawa K, Chugani DC, Asano E, Juhász C, Muzik O, Shah A, Shah J, Sood S, Kupsky WJ, Mangner TJ, Chakraborty PK, Chugani HT (2005) Epilepsy surgery outcome in children with tuberous sclerosis complex evaluated with alpha-[11C]methyl-l-tryptophan positron emission tomography (PET). J Child Neurol 20:429–438
Kaminska A, Chiron C, Ville D, Dellatolas G, Hollo A, Cieuta C, Jalin C, Delalonde O, Fohlen M, Vera P, Soufflet C, Dulac O (2003) Ictal SPECT in children with epilepsy: comparison with intracranial EEG and relation to postsurgical outcome. Brain 126:248–260
Kumlien E, Bergstrom M, Lilja A, Andersson J, Szekeres V, Westerberg CE, Westerberg G, Antoni G, Langstrom B (1995) Positron emission tomography with [11C]deuterium-deprenyl in temporal lobe epilepsy. Epilepsia 36:712–721
Kumlien E, Hartvig P, Valind S, Oye I, Tedroff J, Langstrom B (1999) NMDA-receptor activity visualized with (S)-[N-methyl-11C]ketamine and positron emission tomography in patients with medial temporal lobe epilepsy. Epilepsia 40:30–37
Kuzniecky R, Mountz JM, Wheatley G, Morawetz R (1993) Ictal single-photon emission computed tomography demonstrates localized in cortical dysplasia. Ann Neurol 34:627-631
Kuzniecky RI, Knowlton RC (2002) Neuroimaging of epilepsy. Semin Neurol 22:279–288
Lee SK, Lee SY, Kim KK, Hong KS, Lee DS, Chung CK (2005) Surgical outcome and prognostic factors of cryptogenic neocortical epilepsy. Ann Neurol 58:525–532
Marks DA, Katz A, Hoffer P, Spencer SS (1992) Localization of extratemporal epileptic foci during ictal single photon emission computed tomography. Ann Neurol 31:250–255
Matheja P, Kuwert T, Ludemann P, Weckesser M, Kellinghaus C, Schuierer G, Diehl B, Ringelstein EB, Schober O (2001) Temporal hypometabolism at the onset of cryptogenic temporal lobe epilepsy. Eur J Nucl Med 28:625–632
Meador KJ (2002) Cognitive outcomes and predictive factors in epilepsy. Neurology 58 (Suppl 5):S21–26
Morrell F (1985) Secondary epileptogenesis in man. Arch Neurol 42:318–335
Morrell F (1989) Varieties of human secondary epileptogenesis. J Clin Neurophysiol 6:227–275
Muzik O, da Silva E, Juhász C, Chugani DC, Shah J, Nagy F, Canady A, von Stockhausen HM, Herholz K, Gates J, Frost M, Ritter F, Watson C, Chugani HT (2000) Intracranial EEG vs. flumazenil and glucose PET in children with extratemporal lobe epilepsy. Neurology 54:171–179
O’Brien TJ, So EL, Mullan BP, Hauser MF, Brinkmann BH, Jack CR Jr, Cascino GD, Meyer FB, Sharbrough FW (1999) Subtraction SPECT co-registered to MRI improves postictal SPECT localization of seizure foci. Neurology 52:137–146
Richardson MP, Koepp MJ, Brooks DJ, Fish DR, Duncan JS (1996) Benzodiazepine receptors in focal epilepsy with cortical dysgenesis: an 11C-flumazenil PET study. Ann Neurol 40:188–198
Roach ES (2005) Seeing with new eyes: using positron emission tomography (PET) to identify epileptogenic tubers. J Child Neurol 20:399
Rowe CC, Berkovic SF, Sia ST, Austin M, McKay WJ, Kalnins RM, Bladin PF (1989) Localization of epileptic foci with postictal single photon emission computed tomography. Ann Neurol 26:660–668
Rowe CC, Berkovic SF, Austin MC, McKay WJ, Bladin PF (1991) Patterns of postictal blood flow in temporal lobe epilepsy: qualitative and quantitative analysis. Neurology 41:1096–1103
Sauvageau A, Desjardins P, Lozeva V, Rose C, Hazell AS, Bouthillier A, Butterwort RF (2002) Increased expression of “peripheral-type” benzodiazepine receptors in human temporal lobe epilepsy: implications for PET imaging of hippocampal sclerosis. Metab Brain Dis 17:3–11
Savic I, Persson A, Roland P, Pauli S, Sedvall G, Widen L (1988) In vivo demonstration of reduced benzodiazepine receptor binding in human epileptic foci. Lancet 2:863–866
Savic I, Thorell JO, Roland P (1995) [11C]flumazenil positron emission tomography visualizes frontal epileptogenic regions. Epilepsia 36:1225–1232
Savic I, Blomqvist G, Halldin C, Litton JE, Gulyas B (1998) Regional increases in [11C]flumazenil binding after epilepsy surgery. Acta Neurol Scand 97:279–286
Swartz BE, Theodore WH, Sanabria E, Fisher RS (1992) Positron emission and single photon emission computed tomographic studies in the frontal lobe with emphasis on the relationship to seizure foci. Adv Neurol 57:487–497
Swartz BE, Delgado-Escueta AV, Walsh GO, Rich JR, Dwan PS, DeSalles AA, Kaufman MH (1998) Surgical outcomes in pure frontal lobe epilepsy and foci that mimic them. Epilepsy Res 29:97–108
Szelies B, Sobesky J, Pawlik G, Mielke R, Bauer B, Herholz K, Heiss WD (2002) Impaired benzodiazepine receptor binding in perilesional cortex of patients with symptomatic epilepsies studied by [(11)C]-flumazenil PET. Eur J Neurol 9:137–142
Theodore WH, Dorwart R, Holmes M, Porter RJ, DiChiro G (1986) Neuroimaging in refractory partial seizures: comparison of PET, CT, and MRI. Neurology 36:750–759
Toczek MT, Carson RE, Lang L, Ma Y, Spanaki MV, Der MG, Fazilat S, Kopylev L, Herscovitch P, Eckelman WC, Theodore WH (2003) PET imaging of 5-HT1A receptor binding in patients with temporal lobe epilepsy. Neurology 60:749–756
Van Ness PC (1993) Frontal and parietal lobe epilepsy. In: Wyllie E (ed) The treatment of the epilepsies. Lea & Febinger, Philadelphia, pp 525–532
Vera P, Kaminska A, Cieuta C, Hollo A, Stievenart JL, Gardin I, Ville D, Mangin JF, Plouin P, Dulac O, Chiron C (1999) Use of subtraction ictal SPECT co-registered to MRI for optimizing the localization of seizure foci in children. J Nucl Med 40:786–792
Vinters HV, Fisher RS, Cornford ME, Mah V, Secor DL, De Rosa MJ, Comair YG, Peacock WJ, Shields WD (1992) Morphological substrates of infantile spasms: studies based on surgically resected cerebral tissue. Childs Nerv Syst 8:8–17
Wyllie E, Comair YG, Kotagal P, Bulacio J, Bingaman W, Ruggieri P (1998) Seizure outcome after epilepsy surgery in children and adolescents. Ann Neurol 44:740–748
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sood, S., Chugani, H.T. Functional neuroimaging in the preoperative evaluation of children with drug-resistant epilepsy. Childs Nerv Syst 22, 810–820 (2006). https://doi.org/10.1007/s00381-006-0137-0
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00381-006-0137-0